Physician profile
Dan Liu
NPI 1033565874
$2,061.44
in general payments reported to CMS, 2019-2025
12 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.65 · 2022: $235 · 2023: $378 · 2024: $989 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.61 |
| Travel and Lodging | $434.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $805.30 | 2023-2025 | Hydrus Microstent, Argos, Clareon |
| Abbvie INC. | $307.14 | 2022-2024 | |
| Oyster Point Pharma, INC. | $210.83 | 2022-2025 | Tyrvaya |
| Sight Sciences, INC. | $190.61 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $125.96 | 2023-2025 | Oxervate |
| Glaukos Corporation | $106.80 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $77.08 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $68.53 | 2024 | Tecnis Simplicity |
| Biotissue Holdings INC. | $62.70 | 2024 | |
| Bausch & Lomb Americas INC. | $48.30 | 2025 | Xiidra, Miebo |
| Tarsus Pharmaceuticals, INC. | $37.74 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $20.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.